Ascendis Pharma (ASND) Reports Q3 Loss of EUR1.04

Ascendis Pharma (NASDAQ: ASND) reported Q3 EPS of (EUR1.04), versus (EUR0.72) reported last year.

For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
• Isabella Bank added to Russell 2000 index after Nasdaq listing